<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39316628</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence of SARS-CoV-2 infection in pediatric patients in a tertiary care hospital setting.</ArticleTitle><Pagination><StartPage>e0310860</StartPage><MedlinePgn>e0310860</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0310860</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0310860</ELocationID><Abstract><AbstractText>Globally, cases of children's coronavirus disease 2019 (COVID-19) have been reported since the pandemic started. Most children have an asymptomatic or mild infection. Therefore, the incidence rate of COVID-19 in children might have been underestimated. This study aimed to determine (1) the seroprevalence (and seroconversion rates) of COVID-19, including associated risk factors, in pediatric patients visiting hospitals; and (2) the immunological responses to COVID-19. This was a prospective, cross-sectional study. Patients aged 0-18 years who visited the hospital from September 2020 to February 2022 were included. Demographic, clinical, and laboratory data were reviewed. A total of 1,443 pediatric patients were enrolled. Of these, 323 (22.6%) had a history of COVID-19. In the pre-Delta period, the seroprevalence increased from 4.1% to 70.6% in all included patients and from 0.5% to 10% in patients without a known history of COVID-19 compared with the Delta-Omicron period. The seroconversion rate was 6.8% (19 per 100 person-years) in pediatric patients with COVID-19. Risk factors for COVID-19 seropositivity were respiratory symptoms, being in an outpatient department setting, and infection during the Delta-Omicron period. Exposure to household members with confirmed COVID-19 was a risk factor for seropositivity and seroconversion. Infection during the Delta-Omicron period and testing conducted &gt;2 weeks after the onset of symptoms was associated with spike immunoglobulin (Ig) M and spike and nucleocapsid IgG, respectively. High nucleocapsid IgG levels were associated with pneumonia in pediatric patients with COVID-19. Pediatric patients exposed to household members with COVID-19 and respiratory symptoms should be tested for COVID-19. Nucleocapsid IgG can be used as a surrogate marker to identify patients who may have experienced pneumonia from COVID-19 and as a screening tool for the COVID-19 outbreak, regardless of COVID-19 vaccination status.</AbstractText><CopyrightInformation>Copyright: Â© 2024 Pattanakitsakul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pattanakitsakul</LastName><ForeName>Ploy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pongpatipat</LastName><ForeName>Chanya</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chiangmai Ram Hospital, Chiangmai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Setthaudom</LastName><ForeName>Chavachol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunakorn</LastName><ForeName>Mongkol</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahakijpicharn</LastName><ForeName>Thiantip</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visudtibhan</LastName><ForeName>Anannit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apiwattanakul</LastName><ForeName>Nopporn</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assawawiroonhakarn</LastName><ForeName>Surapat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandee</LastName><ForeName>Uthen</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Techasaensiri</LastName><ForeName>Chonnamet</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonsathorn</LastName><ForeName>Sophida</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaisavaneeyakorn</LastName><ForeName>Sujittra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8166-8691</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="Y">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069078" MajorTopicYN="N">Seroconversion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39316628</ArticleId><ArticleId IdType="pmc">PMC11421809</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0310860</ArticleId><ArticleId IdType="pii">PONE-D-24-06418</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health [Available from: https://pubmed.ncbi.nlm.nih.gov/34003615/.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO COVID-19 dashboard. WHO Health Emergencies Programme. [Available from: https://data.who.int/dashboards/covid19/cases?n=c.</Citation></Reference><Reference><Citation>Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al.. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021;54(1):12â6. doi: 10.1016/j.jmii.2020.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7227597</ArticleId><ArticleId IdType="pubmed">32425996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra K, Malik VS, Padhi BK, Goel S, Gupta M. Asymptomatic infection and transmission of COVID-19 among clusters: systematic review and meta-analysis. Public Health. 2022;203:100â9. doi: 10.1016/j.puhe.2021.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2021.12.003</ArticleId><ArticleId IdType="pmc">PMC8654597</ArticleId><ArticleId IdType="pubmed">35038628</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi D, Nyhoff LE, Zarnitsyna VI, Moreno A, Manning K, Linderman S, et al.. Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults. iScience. 2023;26(10):107967. doi: 10.1016/j.isci.2023.107967</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107967</ArticleId><ArticleId IdType="pmc">PMC10562792</ArticleId><ArticleId IdType="pubmed">37822504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sananez I, Raiden SC, Algieri SC, Uranga M, GrisolÃ­a NA, Filippo D, et al.. A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children. eBioMedicine. 2021;72:103615. doi: 10.1016/j.ebiom.2021.103615</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103615</ArticleId><ArticleId IdType="pmc">PMC8502533</ArticleId><ArticleId IdType="pubmed">34649078</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniu I, Maniu GC, Antonescu E, Duica L, Grigore N, Totan M. SARS- CoV-2 Antibody Responses in Pediatric Patients: A Bibliometric Analysis. Biomedicines. 2023;11(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10216646</ArticleId><ArticleId IdType="pubmed">37239126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Klein J, Sundaram M, Liu F, Wong P, Silva J, et al.. Kinetics of antibody responses dictate COVID-19 outcome. medRxiv. 2020. doi: 10.1101/2020.12.18.20248331</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.18.20248331</ArticleId><ArticleId IdType="pmc">PMC7781347</ArticleId><ArticleId IdType="pubmed">33398304</ArticleId></ArticleIdList></Reference><Reference><Citation>Capelli N, Domitien Payet L, Alcocer Cordellat C, Pisoni A, Engelmann I, Van de Perre P, et al.. SARS-CoV-2 nucleocapsid antigen in plasma of children hospitalized for COVID-19 or with incidental detection of SARS-CoV-2 infection. J Med Virol. 2024;96(1):e29358. doi: 10.1002/jmv.29358</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29358</ArticleId><ArticleId IdType="pubmed">38180230</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman A, Balasubramanian S, Putilibai S, Lakshan Raj S, Amperayani S, Senthilnathan S, et al.. Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Childrenâs Hospital in India. J Trop Pediatr. 2021;67(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989163</ArticleId><ArticleId IdType="pubmed">33693892</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Disease Control MoPH, Thailand. Case definition for patients under investigation (PUIs) with COVID-19. March 1, 2020. [Available from: https://ddc.moph.go.th/viralpneumonia/eng/file/guidelines/g_surveillance_150520.pdf.</Citation></Reference><Reference><Citation>Department of Disease Control. Corona Virus Disease (COVID-19). Guidelines on clinical practice, diagnosis, treatment, and prevention of healthcare-associated infection for COVID-19. Updated 4 August 2021 for medical professionals and public health personnel. [Available from: https://ddc.moph.go.th/viralpneumonia/eng/file/guidelines/g_CPG_04Aug21.pdf.</Citation></Reference><Reference><Citation>Puenpa J, Rattanakomol P, Saengdao N, Chansaenroj J, Yorsaeng R, Suwannakarn K, et al.. Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020â2022. Arch Virol. 2023;168(1):26. doi: 10.1007/s00705-022-05666-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-022-05666-6</ArticleId><ArticleId IdType="pmc">PMC9807426</ArticleId><ArticleId IdType="pubmed">36593392</ArticleId></ArticleIdList></Reference><Reference><Citation>Petcharat S, Supataragul A, Hirunpatrawong P, Torvorapanit P, Klungthong C, Chinnawirotpisan P, et al.. High Transmission Rates of Early Omicron Subvariant BA.2 in Bangkok, Thailand. Adv Virol. 2023;2023:4940767. doi: 10.1155/2023/4940767</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/4940767</ArticleId><ArticleId IdType="pmc">PMC10719011</ArticleId><ArticleId IdType="pubmed">38094619</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Chansaenroj J, Suwannakarn K, Poovorawan Y. Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022-August 2023. Sci Rep. 2024;14(1):645. doi: 10.1038/s41598-023-50856-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-50856-0</ArticleId><ArticleId IdType="pmc">PMC10770311</ArticleId><ArticleId IdType="pubmed">38182705</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra M, Tian R, Zhang C, Clarence E, Sacher CS, Miranda JN, et al.. Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes. Scientific Reports. 2021;11(1):3455. doi: 10.1038/s41598-021-83108-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83108-0</ArticleId><ArticleId IdType="pmc">PMC7875990</ArticleId><ArticleId IdType="pubmed">33568776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Jin F, Cao S, Yuan H, Qu J, Zhang J, et al.. Seroprevalence of SARS-CoV-2 infections among children visiting a hospital. Pediatr Investig. 2020;4(4):236â41. doi: 10.1002/ped4.12231</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ped4.12231</ArticleId><ArticleId IdType="pmc">PMC7768294</ArticleId><ArticleId IdType="pubmed">33376950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenicek Krleza J, Zrinski Topic R, Stevanovic V, Lukic-Grlic A, Tabain I, Misak Z, et al.. Seroprevalence of SARS-CoV-2 infection among children in Childrenâs Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia. Biochem Med (Zagreb). 2021;31(2):020706. doi: 10.11613/BM.2021.020706</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2021.020706</ArticleId><ArticleId IdType="pmc">PMC8047792</ArticleId><ArticleId IdType="pubmed">33927556</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicentini C, Bordino V, Cornio AR, Meddis D, Marengo N, Ditommaso S, et al.. Seroprevalence of infection-induced SARS-CoV-2 antibodies among health care users of Northern Italy: results from two serosurveys (October-November 2019 and September-October 2021). Int J Infect Dis. 2022;124:49â54. doi: 10.1016/j.ijid.2022.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.017</ArticleId><ArticleId IdType="pmc">PMC9477605</ArticleId><ArticleId IdType="pubmed">36116672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran DM, Vu UTT, Hoang CN, Nguyen HTT, Nguyen PH, Tran MCT, et al.. High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Children in Vietnam: An Observational, Hospital-Based Study. Pathogens. 2022;11(12). doi: 10.3390/pathogens11121442</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11121442</ArticleId><ArticleId IdType="pmc">PMC9784013</ArticleId><ArticleId IdType="pubmed">36558776</ArticleId></ArticleIdList></Reference><Reference><Citation>Suntronwong N, Vichaiwattana P, Klinfueng S, Puenpa J, Kanokudom S, Assawakosri S, et al.. SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study. PLoS One. 2023;18(4):e0279147. doi: 10.1371/journal.pone.0279147</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0279147</ArticleId><ArticleId IdType="pmc">PMC10138857</ArticleId><ArticleId IdType="pubmed">37104299</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeimi R, Sepidarkish M, Mollalo A, Parsa H, Mahjour S, Safarpour F, et al.. SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis. EClinicalMedicine. 2023;56:101786. doi: 10.1016/j.eclinm.2022.101786</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101786</ArticleId><ArticleId IdType="pmc">PMC9795163</ArticleId><ArticleId IdType="pubmed">36590788</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucette EJ, Gray J, Fonseca K, Charlton C, Kanji JN, Tipples G, et al.. A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study. PLoS One. 2023;18(4):e0284046. doi: 10.1371/journal.pone.0284046</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0284046</ArticleId><ArticleId IdType="pmc">PMC10079115</ArticleId><ArticleId IdType="pubmed">37023007</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhi SA, Kwatra G, Myers JE, Jassat W, Dhar N, Mukendi CK, et al.. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa. N Engl J Med. 2022;386(14):1314â26. doi: 10.1056/NEJMoa2119658</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2119658</ArticleId><ArticleId IdType="pmc">PMC8908853</ArticleId><ArticleId IdType="pubmed">35196424</ArticleId></ArticleIdList></Reference><Reference><Citation>Chansaenroj J, Suntronwong N, Kanokudom S, Assawakosri S, Vichaiwattana P, Klinfueng S, et al.. Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023. Sci Rep. 2023;13(1):15595. doi: 10.1038/s41598-023-42754-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42754-2</ArticleId><ArticleId IdType="pmc">PMC10511501</ArticleId><ArticleId IdType="pubmed">37730917</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S, Wang L, Zhu Y, Lu L, Jiang S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal Transduction and Targeted Therapy. 2022;7(1):241. doi: 10.1038/s41392-022-01105-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01105-9</ArticleId><ArticleId IdType="pmc">PMC9295084</ArticleId><ArticleId IdType="pubmed">35853878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedenmann M, Ipekci AM, Araujo-Chaveron L, Prajapati N, Lam YT, Alam MI, et al.. SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic review. BMJ Open. 2023;13(10):e072280. doi: 10.1136/bmjopen-2023-072280</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-072280</ArticleId><ArticleId IdType="pmc">PMC10565293</ArticleId><ArticleId IdType="pubmed">37813543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimopoulou D, Kyritsi M, Dadouli K, Vergadi E, Tsiligianni E, Papadimitriou E, et al.. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece. Eur J Pediatr. 2023;182(1):439â49. doi: 10.1007/s00431-022-04681-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04681-8</ArticleId><ArticleId IdType="pmc">PMC9666986</ArticleId><ArticleId IdType="pubmed">36383284</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsawawaranunt K, Thiangthangthum K, Sirikhetkon S, Jampathong P, Kongklieng A, Nakphook S, et al.. Seroprevalence of anti-SARS-CoV-2 antibodies and associated factors among household contacts of COVID-19 confirmed cases in Bangkok, Thailand. Heliyon. 2023;9(5):e16501. doi: 10.1016/j.heliyon.2023.e16501</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e16501</ArticleId><ArticleId IdType="pmc">PMC10198736</ArticleId><ArticleId IdType="pubmed">37251836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubisch U, Sandoni A, Wurm J, Schienkiewitz A, Schlaud M, Kuttig T, et al.. SARS-CoV-2 seroconversion in children attending daycare versus adults in Germany between October 2020 and June 2021. Commun Med (Lond). 2023;3(1):124. doi: 10.1038/s43856-023-00352-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-023-00352-3</ArticleId><ArticleId IdType="pmc">PMC10504330</ArticleId><ArticleId IdType="pubmed">37714948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruedas-Lopez A, Berzosa-Sanchez A, Illan-Ramos M, Callejas-Caballero I, Guillen-Martin S, Bodas-Pinedo A, et al.. Longitudinal survey of humoral and cellular response to SARS-CoV-2 infection in children. Microbiol Res. 2022;264:127145. doi: 10.1016/j.micres.2022.127145</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micres.2022.127145</ArticleId><ArticleId IdType="pmc">PMC9308145</ArticleId><ArticleId IdType="pubmed">35973364</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Baek HJ, Noh E, Yoon K, Kim JA, Ryu S, et al.. Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample. Epidemiol Health. 2023;45:e2023075. doi: 10.4178/epih.e2023075</Citation><ArticleIdList><ArticleId IdType="doi">10.4178/epih.e2023075</ArticleId><ArticleId IdType="pmc">PMC10728614</ArticleId><ArticleId IdType="pubmed">37591786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngandu NK, Mmotsa TM, Dassaye R, Thabetha A, Odendaal W, Langdown N, et al.. Hospital acquired COVID-19 infections amongst patients before the rollout of COVID-19 vaccinations, a scoping review. BMC Infect Dis. 2022;22(1):140. doi: 10.1186/s12879-022-07128-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07128-5</ArticleId><ArticleId IdType="pmc">PMC8830001</ArticleId><ArticleId IdType="pubmed">35144556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hume S, Brown SR, Mahtani KR. School closures during COVID-19: an overview of systematic reviews. BMJ Evid Based Med. 2023;28(3):164â74. doi: 10.1136/bmjebm-2022-112085</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2022-112085</ArticleId><ArticleId IdType="pubmed">37001966</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, et al.. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat Immunol. 2022;23(1):40â9. doi: 10.1038/s41590-021-01089-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01089-8</ArticleId><ArticleId IdType="pmc">PMC8709786</ArticleId><ArticleId IdType="pubmed">34937928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunay GA, Barroso M, Woidy M, Danecka MK, Engels G, Hermann K, et al.. Long-Term Antibody Response to SARS-CoV-2 in Children. Journal of Clinical Immunology. 2023;43(1):46â56. doi: 10.1007/s10875-022-01355-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-022-01355-w</ArticleId><ArticleId IdType="pmc">PMC9483535</ArticleId><ArticleId IdType="pubmed">36121535</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentles LE, Kehoe L, Crawford KHD, Lacombe K, Dickerson J, Wolf C, et al.. Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time. medRxiv. 2022. doi: 10.1101/2022.01.14.22269235</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.14.22269235</ArticleId><ArticleId IdType="pmc">PMC8811949</ArticleId><ArticleId IdType="pubmed">35118481</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostad CA, Chahroudi A, Mantus G, Lapp SA, Teherani M, Macoy L, et al.. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Pediatrics. 2020;146(6). doi: 10.1542/peds.2020-018242</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-018242</ArticleId><ArticleId IdType="pubmed">32879033</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K, et al.. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine. 2020;26(6):845â8. doi: 10.1038/s41591-020-0897-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0897-1</ArticleId><ArticleId IdType="pubmed">32350462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingam G, Periyasami Y, Arjunan P, Subaschandrabose RK, Mathivanan TV, Mathew RS, et al.. Omicron infection increases IgG binding to spike protein of predecessor variants. J Med Virol. 2023;95(2):e28419. doi: 10.1002/jmv.28419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28419</ArticleId><ArticleId IdType="pmc">PMC9880675</ArticleId><ArticleId IdType="pubmed">36546401</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elslande J, Oyaert M, Lorent N, Vande Weygaerde Y, Van Pottelbergh G, Godderis L, et al.. Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection. Diagn Microbiol Infect Dis. 2022;103(1):115659. doi: 10.1016/j.diagmicrobio.2022.115659</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2022.115659</ArticleId><ArticleId IdType="pmc">PMC8837483</ArticleId><ArticleId IdType="pubmed">35278794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne JP, Little BP, Schulte JJ, Haramati A, Haramati LB. Long-term Lung Abnormalities Associated with COVID-19 Pneumonia. Radiology. 2023;306(2):e221806. doi: 10.1148/radiol.221806</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221806</ArticleId><ArticleId IdType="pmc">PMC9462591</ArticleId><ArticleId IdType="pubmed">36040336</ArticleId></ArticleIdList></Reference><Reference><Citation>Prados de la Torre E, Obando I, Vidal M, de Felipe B, Aguilar R, Izquierdo L, et al.. SARS-CoV-2 Seroprevalence Study in Pediatric Patients and Health Care Workers Using Multiplex Antibody Immunoassays. Viruses. 2022;14(9). doi: 10.3390/v14092039</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14092039</ArticleId><ArticleId IdType="pmc">PMC9502584</ArticleId><ArticleId IdType="pubmed">36146844</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HW, Achangwa C, Park J, Lee SM, Lee NY, Jeon CH, et al.. Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea. Front Immunol. 2023;14:1306604. doi: 10.3389/fimmu.2023.1306604</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1306604</ArticleId><ArticleId IdType="pmc">PMC10773891</ArticleId><ArticleId IdType="pubmed">38193075</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>